Clinical Trials
17
Active:11
Completed:4
Trial Phases
2 Phases
Phase 1:2
Not Applicable:2
Drug Approvals
3
SFDA:3
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 1
2 (50.0%)No trials found
News
X-Chem and Orion Pharma Expand Collaboration to Accelerate Small Molecule Drug Discovery
X-Chem and Orion Pharma have expanded their strategic collaboration from hit identification to candidate selection, leveraging DNA-encoded library technology and AI-driven approaches for multiple early-stage programs.
Bayer Secures FDA Approval for Nubeqa in Metastatic Prostate Cancer, Targeting €3 Billion Peak Sales
Bayer received FDA approval for Nubeqa (darolutamide) in combination with docetaxel chemotherapy for metastatic hormone-sensitive prostate cancer, expanding beyond its initial non-metastatic indication.
AI-Powered HASTEN Tool Accelerates Virtual Drug Screening 10-Fold
Finnish researchers have developed an ML-powered tool called HASTEN that reduces virtual drug screening time from 6 months to under 10 days for 1.56 billion molecules.